Home › NDC Lookup › RxCUI directory › RxCUI 403920

Daptomycin 500 MG Injection — RxCUI 403920

RxNorm drug concept · Semantic clinical drug
RxCUI 403920 Semantic clinical drug · SCD ● Current RxNorm concept 37 FDA products 37 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI403920
Official nameDaptomycin 500 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped37
Package NDCs mapped37
Reported Medicaid activity (SDUD)93,963 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Daptomycin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It is an antibiotic for complicated skin infections and for S. aureus bloodstream infections, including right-sided endocarditis in adults. It is used in adults and in children 1 t...
  • A healthcare professional gives it through a vein, generally once a day. Adults may get a quick 2-minute injection or a 30-minute infusion. Children get an infusion only.
  • Diarrhea, headache, dizziness, rash and itching are among the more common ones. Blood tests may show raised CPK or liver values. Children may also have vomiting or fever.
  • Get help right away for trouble breathing, swelling or a serious allergic reaction. Also report muscle pain or weakness, new cough with fever, severe rash, numbness or tingling, or...
📖 Read our full Daptomycin Injection guide →

🕸️ Concept Web — How Daptomycin 500 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Daptomycin 500 MG Injection RxCUI 403920

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Daptomycin 22299
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cubicin 404965
    • Dapzura 2591789
  3. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Daptomycin Injection 1731096
    • Daptomycin Injectable Product 1152143
    • Daptomycin Injection [Cubicin] 1731099
    • Daptomycin Injection [Dapzura] 2591792
    • Cubicin Injectable Product 1173079
    • Dapzura Injectable Product 2591791
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Daptomycin 500 MG 1731095
    • Daptomycin 500 MG Injection [Cubicin] 404652
    • Daptomycin 500 MG Injection [Dapzura] 2591793
    • Daptomycin 500 MG [Cubicin] 1731098
    • Daptomycin 500 MG [Dapzura] 2591790

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Daptomycin 500 MG SCDC · 1731095
  • Daptomycin Injection SCDF · 1731096
  • Daptomycin Injectable Product SCDG · 1152143

Brand-Name Concepts

  • Daptomycin 500 MG Injection [Dapzura] SBD · 2591793
  • Daptomycin 500 MG Injection [Cubicin] SBD · 404652
  • Daptomycin 500 MG [Cubicin] SBDC · 1731098
  • Daptomycin 500 MG [Dapzura] SBDC · 2591790
  • Daptomycin Injection [Cubicin] SBDF · 1731099
  • Daptomycin Injection [Dapzura] SBDF · 2591792
  • Cubicin Injectable Product SBDG · 1173079
  • Dapzura Injectable Product SBDG · 2591791
  • Cubicin BN · 404965
  • Dapzura BN · 2591789

📦 FDA Products & Package NDCs

37 products · 37 package NDCs
37 package NDCs map to RxCUI 403920 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9378-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0143-9378-01) / 10 mL in 1... Daptomycin Hikma Pharmaceuticals USA Inc. 2020-01-01
00143-9444-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0143-9444-01) / 10 mL in 1... Daptomycin Hikma Pharmaceuticals USA Inc. 2025-09-30
00143-9445-01 1 VIAL, SINGLE-USE in 1 CARTON (0143-9445-01) / 10 mL in 1... Daptomycin Hikma Pharmaceuticals USA Inc. 2025-12-11
00143-9456-01 1 VIAL, SINGLE-USE in 1 CARTON (0143-9456-01) / 7 mL in 1 V... Daptomycin Hikma Pharmaceuticals USA Inc. 2025-12-11
00143-9465-01 1 VIAL, SINGLE-USE in 1 CARTON (0143-9465-01) / 10 mL in 1... Daptomycin Hikma Pharmaceuticals USA Inc. 2025-09-30
00409-0120-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0120-01) / 7 mL in 1... Daptomycin Hospira, Inc. 2021-08-02
00409-0122-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0122-01) / 10 mL in 1... Daptomycin Hospira, Inc. 2021-08-02
14335-0120-01 20 mL in 1 VIAL, SINGLE-DOSE (14335-120-01) daptomycin Hainan Poly Pharm., Co., Ltd. 2023-11-14
16729-0435-05 1 VIAL, SINGLE-DOSE in 1 CARTON (16729-435-05) / 10 mL in 1... DAPTOMYCIN Accord Healthcare Inc. 2019-06-24
25021-0174-15 1 VIAL in 1 CARTON (25021-174-15) / 10 mL in 1 VIAL daptomycin Sagent Pharmaceuticals 2019-11-15
25021-0174-16 10 VIAL in 1 CARTON (25021-174-16) / 10 mL in 1 VIAL daptomycin Sagent Pharmaceuticals 2019-11-15
31722-0216-01 1 VIAL, SINGLE-DOSE in 1 CARTON (31722-216-01) / 10 mL in 1... Daptomycin Camber Pharmaceuticals, Inc. 2022-09-23
42023-0295-10 10 VIAL, SINGLE-DOSE in 1 CARTON (42023-295-10) / 1 INJECTI... Daptomycin Par Health USA, LLC 2025-10-27
43598-0413-11 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-413-11) / 10 mL in 1... Daptomycin Dr.Reddy's Laboratories Inc., 2019-05-01
55150-0344-01 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-344-01) / 10 mL in 1... DAPTOMYCIN Eugia US LLC 2021-09-02
60505-6229-04 1 VIAL, SINGLE-USE in 1 CARTON (60505-6229-4) / 10 mL in 1... Daptomycin APOTEX CORP. 2022-02-23
63323-0371-10 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-371-10) / 10 mL in 1... Daptomycin Fresenius Kabi USA, LLC 2018-04-11
63323-0371-19 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-371-19) / 10 mL in 1... Daptomycin Fresenius Kabi USA, LLC 2018-04-11
67184-0549-01 1 VIAL, SINGLE-USE in 1 CARTON (67184-0549-1) / 10 mL in 1... Daptomycin Qilu Pharmaceutical Co., Ltd. 2021-08-24
67457-0813-50 1 VIAL, SINGLE-DOSE in 1 CARTON (67457-813-50) / 10 mL in 1... daptomycin Mylan Institutional LLC 2018-09-04
67457-0941-15 1 VIAL, SINGLE-DOSE in 1 CARTON (67457-941-15) / 10 mL in 1... daptomycin Mylan Institutional LLC 2023-11-27
68001-0376-68 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-376-68) / 10 mL in 1... Daptomycin BluePoint Laboratories 2019-05-01
70377-0093-91 1 VIAL, SINGLE-USE in 1 CARTON (70377-093-91) / 10 mL in 1... Daptomycin Biocon Pharma Inc. 2024-10-25
70436-0033-80 20 mL in 1 VIAL, SINGLE-DOSE (70436-033-80) daptomycin Slate Run Pharmaceuticals, LLC 2022-10-01
70511-0182-84 10 VIAL, SINGLE-DOSE in 1 CARTON (70511-182-84) / 1 INJECTI... Daptomycin MAIA Pharmaceuticals, Inc. 2025-09-08
70594-0034-01 1 VIAL, SINGLE-USE in 1 CARTON (70594-034-01) / 10 mL in 1... Daptomycin Xellia Pharmaceuticals USA LLC 2018-10-01
70594-0034-02 1 VIAL, SINGLE-USE in 1 CARTON (70594-034-02) / 10 mL in 1... Daptomycin Xellia Pharmaceuticals USA LLC 2021-05-01
70594-0060-01 1 VIAL, SINGLE-USE in 1 CARTON (70594-060-01) / 10 mL in 1... Daptomycin Xellia Pharmaceuticals USA LLC 2023-11-03
70594-0066-01 1 VIAL, SINGLE-USE in 1 CARTON (70594-066-01) / 7 mL in 1 V... Daptomycin Xellia Pharmaceuticals USA LLC 2023-11-03
71288-0016-15 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-016-15) / 10 mL in 1... DAPTOMYCIN Meitheal Pharmaceuticals Inc. 2021-06-29
71288-0016-91 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-016-91) / 10 mL in 1... DAPTOMYCIN Meitheal Pharmaceuticals Inc. 2021-06-29
71288-0016-95 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-016-95) / 10 mL in 1... DAPTOMYCIN Meitheal Pharmaceuticals Inc. 2021-06-29
71839-0107-01 1 VIAL, SINGLE-DOSE in 1 CARTON (71839-107-01) / 10 mL in 1... daptomycin BE Pharmaceuticals Inc. 2019-06-26
72572-0102-01 1 VIAL, SINGLE-USE in 1 CARTON (72572-102-01) / 10 mL in 1... Daptomycin Civica, Inc. 2019-08-20
72572-0158-01 1 VIAL, SINGLE-USE in 1 CARTON (72572-158-01) / 10 mL in 1... Daptomycin Civica, Inc. 2025-11-28
72603-0152-01 1 VIAL, SINGLE-DOSE in 1 CARTON (72603-152-01) / 10 mL in 1... Daptomycin NorthStar RxLLC 2023-04-18
83090-0011-01 1 VIAL, SINGLE-DOSE in 1 CARTON (83090-011-01) / 10 mL in 1... daptomycin Sintetica US LLC 2023-11-05
Observed labelers: Hikma Pharmaceuticals USA Inc. (5) · Xellia Pharmaceuticals USA LLC (4) · Meitheal Pharmaceuticals Inc. (3) · Civica, Inc. (2) · Fresenius Kabi USA, LLC (2) · Hospira, Inc. (2) · +18 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0878 Daptomycin injection 21 CMS
J0877 Inj, daptomycin (hospira) 4 CMS
J0872 Daptomycin (xellia) unrefrig 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.